help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leri, A.
Right arrow Articles by Anversa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leri, A.
Right arrow Articles by Anversa, P.
(American Journal of Pathology. 2000;156:1663-1672.)
© 2000 American Society for Investigative Pathology

Regular Articles

Up-Regulation of AT1 and AT2 Receptors in Postinfarcted Hypertrophied Myocytes and Stretch-Mediated Apoptotic Cell Death

Annarosa Leri*, Yu Liu*, Baosheng Li*, Fabio Fiordaliso*, Ashwani Malhotra*, Roberto Latini{dagger}, Jan Kajstura* and Piero Anversa*

From the Department of Medicine,*
New York Medical College, Valhalla, New York; and the Istituto di Ricerche Farmacologiche Mario Negri,{dagger}
Milano, Italy

To determine whether up-regulation of AT1 and AT2 receptors occurred in hypertrophied myocytes after infarction and whether AT2 played a role in stretch-mediated apoptosis, left ventricular myocytes were dissociated from the surviving portion of the wall 8 days after coronary occlusion and cardiac failure in rats. Control cells were obtained from sham-operated animals. Myocytes were stretched in an equibiaxial stretch apparatus and angiotensin II (Ang II) formation and cell death were measured 3 and 12 hours later. AT1 and AT2 proteins were evaluated in freshly isolated myocytes and after stretch. The effects of AT1 and AT2 antagonists on stretch-induced Ang II synthesis and apoptosis were also established. Myocardial infarction increased AT1 and AT2 in myocytes and stretch further up-regulated these receptors. Ang II levels were higher in postinfarcted myocytes and this peptide increased with the duration of stretch in both groups of cells. Similarly, apoptosis increased with time in control and postinfarcted myocytes. Absolute values of Ang II and apoptosis were greater in myocytes from infarcted hearts at 3 and 12 hours after stretch. Addition of AT1 blocker to cultures inhibited stretch-activated apoptosis in both myocyte populations as well as the generation of Ang II in postinfarcted myocytes. In contrast, AT2 antagonists had no impact on these cellular events. In conclusion, Ang II stimulated cell death through AT1 receptor activation, whereas ligand binding to AT2 receptor did not alter Ang II concentration and apoptosis in normal and postinfarcted hypertrophied myocytes.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Xu, O. A. Carretero, C.-X. Lin, M. A. Cavasin, E. G. Shesely, J. J. Yang, T. L. Reudelhuber, and X.-P. Yang
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1900 - H1907.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Kasama, T Toyama, T Hatori, H Sumino, H Kumakura, Y Takayama, S Ichikawa, T Suzuki, and M Kurabayashi
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure
Heart, May 1, 2006; 92(5): 625 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. L. Brunton
A positive feedback loop contributes to the deleterious effects of angiotensin
PNAS, October 11, 2005; 102(41): 14483 - 14484.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Ding, J.-i. Abe, H. Wei, H. Xu, W. Che, T. Aizawa, W. Liu, C. A. Molina, J. Sadoshima, B. C. Blaxall, et al.
A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis
PNAS, October 11, 2005; 102(41): 14771 - 14776.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev, October 1, 2005; 85(4): 1373 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G.-D. Wang, X.-Y. Wang, H.-Z. Hu, X.-C. Fang, S. Liu, N. Gao, Y. Xia, and J. D. Wood
Angiotensin receptors and actions in guinea pig enteric nervous system
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G614 - G626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Tan, H. Wang, and F. H. H. Leenen
Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1665 - H1671.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
A. Tzanidis, R. D. Hannan, W. G. Thomas, D. Onan, D. J. Autelitano, F. See, D. J. Kelly, R. E. Gilbert, and H. Krum
Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy
Circ. Res., August 8, 2003; 93(3): 246 - 253.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Addition of Valsartan to an Angiotensin-Converting Enzyme Inhibitor Improves Cardiac Sympathetic Nerve Activity and Left Ventricular Function in Patients with Congestive Heart Failure
J. Nucl. Med., June 1, 2003; 44(6): 884 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
V. G. Sharov, A. Todor, G. Suzuki, H. Morita, E. J. Tanhehco, and H. N. Sabbah
Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1
Eur J Heart Fail, March 1, 2003; 5(2): 121 - 129.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. B. Ratcliffe
Non-ischemic infarct extension: A new type of infarct enlargement and a potential therapeutic target
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1168 - 1171.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan
Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor
Circ. Res., February 8, 2002; 90(2): 135 - 142.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. N. Cohn, G. Tognoni, and the Valsartan Heart Failure Trial Investigators
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
N. Engl. J. Med., December 6, 2001; 345(23): 1667 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Dalla Libera, B. Ravara, A. Angelini, K. Rossini, M. Sandri, G. Thiene, G. Battista Ambrosio, and G. Vescovo
Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure
Circulation, May 1, 2001; 103(17): 2195 - 2200.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. Barlucchi, A. Leri, D. E. Dostal, F. Fiordaliso, H. Tada, T. H. Hintze, J. Kajstura, B. Nadal-Ginard, and P. Anversa
Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure
Circ. Res., February 16, 2001; 88(3): 298 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan
Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor
Circ. Res., February 8, 2002; 90(2): 135 - 142.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.